CPhI Global Events
Ingredients & Formulation
Manufacturing & Outsourcing
Packaging & Drug Delivery
Middle East & Africa
Ingredients & Formulation
BROUGHT TO YOU BY
Pharmaceutical ingredients and formulation, from APIs and Excipients to Natural Extracts
CPhI Webinar Series
A series of five webinars addressing the impact of COVID-19 on the pharma industry
US government signs $354 million generics and API manufacturing contract with Phlow
May 19, 2020
Pharma start-up will use continuous manufacturing to shore up supply chain of essential medicines
CPhI Webinar Series - Pharma Action Against COVID-19 – Listen Now
May 11, 2020
Listen to recordings of all webinars broadcast during the week of May 04-08
Is COVID-19 the catalyst for Western pharma markets to revert to domestic API production?
May 07, 2020
The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are...
Evonik launches European API manufacturing capacity expansion programme
May 06, 2020
EUR 25 million first stage expected to be completed by mid-2021 as COVID-19 pandemic highlights need for more European capacity
Strides starts exports of generic version of Avigan for COVID-19 treatment
Apr 29, 2020
Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM
Nitrosamine contamination: pharma’s re-evaluation of its supply chain
Apr 17, 2020
The detection of nitrosamine impurities in some finished dosages has opened up a whole new set of challenges for API manufacturers who need to perform risk evaluations of their processes
Lupin receives FDA all-clear for Mandideep API manufacturing facility
Apr 15, 2020
Company becomes the fourth Indian pharma firm to secure FDA clearance in the last two weeks
India says shipments of hydroxychloroquine will resume after US exerts pressure
Apr 07, 2020
Move comes 24 hours after US President warns of "retaliation" if export ban was not lifted
The Future of Medicine: What are the therapies of tomorrow?
Apr 01, 2020
As biopharma heads towards a new decade, extracting value from innovation remains a key theme in medicines development...
Global API Snapshot: Pharma Demands and Evolving Markets
Mar 22, 2020
Fierce competition in the low cost, high volume API sector is forcing suppliers to invest in capacity and accelerate throughout.
Generics Boom: Growing Global Demand Reshaping Sector
Mar 20, 2020
Despite consolidation, competition between manufacturers is fierce and the generic drug market continues to grow.
Artificial Intelligence: Moving beyond efficiency gains in drug development
Mar 16, 2020
Is the pharma industry making the most of AI’s potential when it comes to accelerating and enhancing pharmaceutical drug development?